State Laboratory Reporting Laws: Viral Load and CD4 Requirements
Data on viral load and CD4 counts for persons who are HIV-infected can provide information about the effectiveness of prevention and treatment programs.
Viral load measurements indicate the number of copies of the HIV-1 virus that are in a milliliter of a person’s blood. CD4 results provide a measure of a person’s immune function and give information about a person’s white blood cells. Among people with HIV, CD4 results are often used to monitor disease progression, determine the stage of HIV infection, and make decisions about when particular treatments are appropriate. In addition, both viral load and CD4 data are used to assess whether patients are responding to treatment: when treatment is successful, CD4 counts rise and viral loads fall. Current HIV clinical management guidelines call for CD4 and viral load testing at the time of diagnosis and regularly thereafter. When all CD4 and viral load results are reported, public health agencies can determine access to care and treatment outcomes.
While all states in the United States have enacted laws or regulations requiring laboratory reporting, not all of the laws require reporting of all CD4 and viral load results. Currently, 40 states plus D.C. have enacted laws, regulations, or directives that specifically require laboratory reporting of all levels of CD4 and both detectable and undetectable viral loads of all HIV-positive individuals (click here to find out about specific states). For more information concerning the importance of CD4 and Viral Load reporting, see Dear Colleague Letter from Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, to HIV Surveillance coordinators, AIDS Directors, State Epidemiologists, State Health Officers, and State Public Health Lab Directors about laboratory reporting of HIV-related tests, including all CD4+ T-lymphocyte (CD4) results and all viral load test results. CDC 2013.
Find an HIV testing site near you.
Search location, such as: "Atlanta, GA", or "30033".
For more information, please visit gettested.cdc.gov
Please contact GETTESTED-Webmaster@cdc.gov with any comments, suggestions, or concerns.
- HIV Basics
- Who's at Risk for HIV?
- Risk Behavior
- Racial/Ethnic Groups
- HIV Testing
- Prevention Research
- Pre-Exposure Prophylaxis (PrEP)
- Prevention Benefits of HIV Treatment
- Replicating Effective Programs Plus (REP)
- Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention
- Demonstration Projects
- Ongoing Research
- The Serostatus Approach to Fighting the HIV Epidemic
- Policies and Programs
- Affordable Care Act
- DHAP Annual Report
- DHAP Strategic Plan
- Expanded Testing Initiative
- Funding Announcements
- Funding Awards 2012
- Funding Awards 2011
- Funding Awards 2010
- Funding Awards 2009
- Questions and Answers
- Letter of Intent
- Workshops and Web Conferences
- Eligibility Criteria and Maps of MSAs and MDs
- After You Apply
- New Awards for 12-1201
- FY 2012 Funding for Category C
- Grantee Orientation Materials
- Comprehensive Program Plan
- HIV Planning Guidance
- Capacity Building Assistance for Health Departments
- Related Links
- High Impact Prevention
- HIV-Related Laws
- Progress Reports
- Program Planning
- Guidelines and Recommendations
- Training and Conferences
- Statistics Center
- Statistics Overview
- Surveillance Overview
- Surveillance Systems
- Surveillance Reports and Slide Sets
- Recommendations and Guidelines
- Other Resources
- Resource Library